ContractConfirmation of Otc Convertible Note Hedge • February 23rd, 2009 • Mylan Inc. • Pharmaceutical preparations
Contract Type FiledFebruary 23rd, 2009 Company IndustryTHIS CONFIRMATION AMENDS, REPLACES, SUPERSEDES AND RESTATES IN ITS ENTIRETY ALL PREVIOUS CONFIRMATIONS PERTAINING TO THIS TRANSACTION.
AMENDMENT NO. 1 TO TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • February 23rd, 2009 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledFebruary 23rd, 2009 Company Industry JurisdictionTHIS AMENDMENT TO THE TRANSITION AND SUCCESSION AGREEMENT (this “Amendment”) by and between Mylan Inc. (the “Company”) and Rajiv Malik (the “Executive”), is made as of December 22, 2008.
AMENDMENT NO. 2 TO RETIREMENT BENEFIT AGREEMENTRetirement Benefit Agreement • February 23rd, 2009 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledFebruary 23rd, 2009 Company Industry JurisdictionTHIS AMENDMENT TO THE RETIREMENT BENEFIT AGREEMENT (this “Amendment”) by and between Mylan Inc. (the “Company”) and Edward J. Borkowski (“Executive”), is made as of December 22, 2008.
AMENDMENT NO. 3 TO TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • February 23rd, 2009 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledFebruary 23rd, 2009 Company Industry JurisdictionTHIS AMENDMENT TO THE TRANSITION AND SUCCESSION AGREEMENT (this “Amendment”) by and between Mylan Inc. (the “Company”) and Robert J. Coury (the “Executive”), is made as of December 22, 2008.
SEPARATION AGREEMENT AND RELEASESeparation Agreement • February 23rd, 2009 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledFebruary 23rd, 2009 Company Industry JurisdictionThis Separation Agreement and Release (“Agreement”) is made by and between Edward J. Borkowski (“Executive”) and Mylan Inc. (the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
AMENDMENT NO. 3 TO TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • February 23rd, 2009 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledFebruary 23rd, 2009 Company Industry JurisdictionTHIS AMENDMENT TO THE TRANSITION AND SUCCESSION AGREEMENT (this “Amendment”) by and between Mylan Inc. (the “Company”) and Edward J. Borkowski (the “Executive”), is made as of December 22, 2008.
AMENDMENT NO. 3 TO EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 23rd, 2009 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledFebruary 23rd, 2009 Company Industry JurisdictionTHIS AMENDMENT TO THE EXECUTIVE EMPLOYMENT AGREEMENT (this “Amendment”) by and between Mylan Inc. (the “Company”) and Edward J. Borkowski (“Executive”), is made as of December 22, 2008.
AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 23rd, 2009 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledFebruary 23rd, 2009 Company Industry JurisdictionTHIS AMENDMENT TO THE EXECUTIVE EMPLOYMENT AGREEMENT (this “Amendment”) by and between Mylan Inc. (the “Company”) and Heather Bresch (“Executive”), is made as of December 22, 2008.
AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 23rd, 2009 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledFebruary 23rd, 2009 Company Industry JurisdictionTHIS AMENDMENT TO THE EXECUTIVE EMPLOYMENT AGREEMENT (this “Amendment”) by and between Mylan Inc. (the “Company”) and Rajiv Malik (“Executive”), is made as of December 22, 2008.
AMENDMENT TO THE AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 23rd, 2009 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledFebruary 23rd, 2009 Company Industry JurisdictionTHIS AMENDMENT TO THE AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Amendment”) by and between Mylan Inc. (the “Company”) and Robert J. Coury (the “Executive”), is made as of December 22, 2008.